Live style and risk of lifestyle diseases

Czech version

Authors: Jan Kábrt
Authors‘ workplace: Klinika Program H plus Praha, ředitelka společnosti Monika Šubrtová
Published in: Vnitř Lék 2014; 60(5-6): 458-461
Category: Review

Overview

Metabolic syndrome included obesity, diabetes mellitus type II, hypertension and disorder of lipid metabolism are serious complication affecting many people of economic advanced countries. Unhealthy live style with limited physical activity and overfeeding are the main cause of this disorder. Adjustment of the live style with regular physical activity has the better result compared with a diet intervention alone.

Key words:
abdominal obesity –⁠ live style –⁠ metabolic syndrome –⁠ physical activity

Sources

1. DeFronzo RA, Ferrannini E. Insulin resistence: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease. Diabetes care 1991; 14(3): 173–194.

2. Kaplan NM. The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceredemia and hypertension. Arch Intern Med 1989; 149(7): 1514–1520.

3. Reaven GM. Role of insulin resistence in human disease. Diabetes 1988; 37(12): 1595–1607.

4. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).JAMA 2001; 285(19): 2486–2497.

5. Neel JV. Diabetes mellitus: a "thrifty" genotype rendered detrimental by "progress"? Am J Hum Genet 1962; 14 : 353–362.

6. Svobodová Š, Topolčan O. Metabolický syndrom, predikce a prevence. Interní Med 2012; 14(11): 412–414.

7. Šobra J. Proč zbytečně umíráme : esej o současném člověku v epidemii srdečně-cévních onemocnění, která chce oslovit ty, jež chtějí vědět. Radix: Praha 1996. ISBN 80–86031–06–3.

8. The Framingham Offspring Study: a commentary. 1980. JACC 1999; 33(5): 1136–1140.

9. Matoulek M, Svačina Š, Lajka J. Výskyt obezity a přidružených onemocnění v ČR. Vnitř Lék 2010; 56(10): 1019–1027.

10. Trayhurn P, Wood IS. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 2004; 92(3): 347–355.

11. Browning ID, Szczenaniak IS et al. Prevalance of hepatis steatosis in an urban population in the United States. Impact of etnicity. Hepatology 2004; 40(6):1387–1395.

12. Zimmet PZ, Alberti KG, Shaw JE. Mainstreaming the metabolic syndrome: a definite definition. Med J Aust 2005; 15 : 183(4): 175–176.

13. Orchard TJ, Temprosa M et al. The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Preventive Program randomized trial. Ann Intern Med 2005; 142(8): 611–619.

14. Yamaoka J, Tango T. Effects of lifestyle modification on metabolic syndrome: a systematic review and meta-analysis. BMC Med 2012; 10 : 138. Dostupné z DOI: <http://doi: 10.1186/1741–7015–10–138>.

15. Svačina Š et al. Metabolický syndrom. Grada Publishing: Praha 2011. ISBN 978–80–247–4092–8.

16. Doležalová R, Haluzík M. Metabolický syndrom a fyzická aktivita. In: Svačina Š (ed). Trendy soudobé diabetologie. Galén: Praha 2005. ISBN 80–7262–359–1.

17. Collins F. Řeč života. Academia: Praha 2012. ISBN 978–80–200–2161–8.